Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Brittany DeBerry"'
Autor:
Alyssa Simonson, Johnnie Flores, Ebony Anderson, Crystal Moreno, George Plasko, Kyriakos P. Papadopoulos, Amita Patnaik, Drew Rasco, Gladys Rodriguez, Amy Lang, Muralidhar Beeram, Luis Rodriguez, Ronald Drengler, Steven Abbate, Hanni Salih, Lon Smith, Maryam Elmi, Brittany DeBerry, Arthur Rosenthal, Tatiana Hernandez, Nehal Lakhani, Manish Sharma, Michael Wick
Publikováno v:
Cancer Research. 83:P3-08
Background: Sacituzumab govitecan (SG) is an antibody-drug conjugate targeting Trop2 with an SN-38 payload recently approved for pretreated patients with locally advanced or metastatic triple-negative breast cancer (TNBC). The XenoSTART Patient-Deriv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d808a47f1b81f2dd82b9dfcad41380da
https://doi.org/10.1158/1538-7445.sabcs22-p3-08-05
https://doi.org/10.1158/1538-7445.sabcs22-p3-08-05
Autor:
Alyssa Simonson, Peter Forofontov, Johnnie R Flores, Kimberly Hernandez, April Cabang, Amy Lang, Gladys Rodriguez, Kyriakos Papadopoulos, Murali Beeram, Arthur Rosenthal, Brittany DeBerry, Lon Smith, Ronald Drengler, Amita Patnaik, Drew Rasco, Luis Rodriguez, Steven Abbate, Scott Ulmer, Michael Wick
Publikováno v:
Cancer Research. 82:P5-01
Background: 15-20% of metastatic breast cancers are characterized by overexpression or amplification of human epidermal growth factor receptor 2 (HER2). First-line treatment for HER2-positive metastatic breast cancer includes the anti-HER2 monoclonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c958461699cc496c9ce2fded49667d9a
https://doi.org/10.1158/1538-7445.sabcs21-p5-01-04
https://doi.org/10.1158/1538-7445.sabcs21-p5-01-04